The Sunespro project was born in 2017 with the aim of developing nutritional supplements that help improve the nutritional status of patients with chronic diseases, specifically chronic kidney disease on hemodialysis and Crohn's disease.

For the development of Sunespro, Adventia Pharma
participates with the following entities:

The Sunespro project is funded by ERDF / Ministry of Science, Innovation and Universities - State Research Agency / _Project RTC-2017-5959-1